ACM
LEGN icon

Aquatic Capital Management’s Legend Biotech LEGN Stock Holding History

Aquatic Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,314
Closed -$639K – 1518
2026
Q1 		$639K Buy
35,314
+33,882
+2,366% +$646K 0.02% 683
2025
Q4 		$31.1K Sell
1,432
-95,336
-99% -$2.73M ﹤0.01% 1289
2025
Q3 		$3.16M Buy
+96,768
New +$3.57M 0.06% 387
2025
Q2 		– Sell
-36,175
Closed -$1.23M – 1406
2025
Q1 		$1.23M Buy
+36,175
New +$1.3M 0.03% 542
2024
Q2 		– Sell
-27,700
Closed -$1.55M – 1434
2024
Q1 		$1.55M Buy
27,700
+12,500
+82% +$754K 0.05% 299
2023
Q4 		$915K Buy
15,200
+900
+6% +$57K 0.02% 495
2023
Q3 		$961K Buy
14,300
+13,500
+1,688% +$938K 0.04% 350
2023
Q2 		$55K Buy
+800
New +$52.3K ﹤0.01% 973

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Aquatic Capital Management's LEGN Position: Q2 2026 in Review

Aquatic Capital Management sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 35,314 shares — an estimated $639K sold.

Aquatic Capital Management first reported a position in LEGN in Q2 2023 and held it in 8 quarters. The position peaked at $3.16M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Aquatic Capital Management reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 35,314 Legend Biotech shares in Q2 2026, an estimated $639K.
  • Aquatic Capital Management first reported a position in Legend Biotech in Q2 2023 and held it in 8 quarters.
  • Aquatic Capital Management's Legend Biotech position peaked at $3.16M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.